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Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is one of the most frequent
ocular disorders. It may lead to progressive corneal opacification and blindness (1). Sec-
retory, neuronal and mechanical processes that regulate the production and mixing of
tear film constituents are functionally integrated (2). The ageing process, hormonal, en-
vironmental, iatrogenic, pharmacological and pathogenic factors may disrupt the tear film
with subsequent ocular surface inflammation (3). The hyperosmolar tear film stimulates
the production of mitogen-activated protein kinase (4). This initiates a cascade of protein
phosphorylation involving other kinases and nuclear transcription factors which stimu-
late the proinflammatory cytokines and chemokines in tear fluid and conjunctival epi-
thelium in KCS (5).
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The purpose of this study was to compare the topical an-
ti-inflammatory effects of the nonselective cyclooxyge-
nase (COX) inhibitor, ketorolac, with the selective COX-2
inhibitor, nimesulide, in an animal model of dry eye in
albino rabbits. All animals were examined by the Schir-
mer test, tear break-up time (TBUT) and fluorescein cor-
neal staining test. Dry eye model showed significant re-
duction in tear volume, TBUT, corneal staining and
histopathological signs of dryness and inflammation. On
treating dry eye model with nimesulide 0.1% eye drops
and ketorolac 0.5% eye drops, there were improvements
in Schirmer test values, TBUT and fluorescein corneal
staining and histopathologically reduced inflammatory
reaction, with signs of healing and regeneration. Both ni-
mesulide and ketorolac ameliorate atropine sulphate in-
duced dry eye in albino rabbits. The use of selective
COX-2 inhibitor, nimesulide, is preferred to avoid local
and systemic side effects which may occur with the use
of the nonselective COX inhibitor, ketorolac.
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Use of artificial tears is palliative, with some transient symptomatic relief. Inflam-
matory phenomena may exist even in an apparently normal eye, where they remain sub-
clinical (6). Therefore, pharmacological treatment strategies are targeted specifically
against predominant inflammatory mediators. Nonsteroidal anti-inflammatory drugs
(NSAIDs) are currently used (7). The nonselective NSAID group inhibits both COX-1
and COX-2 enzymes. Although inhibition of COX-2 enzyme is required for inhibition of
the production of inflammatory prostaglandins (PGs), inhibition of COX-1 enzyme is
not required because it leads to inhibition of the production of physiological PGs invol-
ved in the normal regulation of intraocular pressure and blood aqueous barrier (8). Ni-
mesulide is a NSAID that belongs to COX-2 preferential inhibitors. It inhibits inflamma-
tory PGs, platelet activating factor, tumor necrosis factor, proteinase, histamine, bradyki-
nin and cytokine induced hyperalgesia (9). In addition, it antagonizes H1-histamine re-
ceptor activation (10). The present investigation is designed to compare the topical non-
selective COX inhibitor, ketorolac, with the selective COX-2 inhibitor, nimesulide, in
treating an animal model of dry eye in albino rabbits.
EXPERIMENTAL
In the dry eye model, the ocular surface tissues (cornea, conjunctiva, accessory lacri-
mal glands, meibomian glands and main lacrimal glands) interconnected by neuronal
reflex loops were inhibited by the use of atropine sulphate 1% eye drops (Orchidia Phar-
ma, Egypt) (11).
Animals
Eighteen healthy adult male New Zealand albino rabbits, weighing 1.5–2 kg, aged
3–3.5 months, were used. They were individually housed in separate cages under stan-
dardized temperature (25–28 °C), humidity (50–60%), and light (12 hours light-dark)
conditions. They were fed the standard diet and tap water. All care and handling of rab-
bits adhered to the ARVO statement for the use of animals in ophthalmic and vision re-
search, with approval of the institutional authority for laboratory animal care and ap-
proval from the ethical committee. In all animals, treatments were applied topically in
both eyes, three times daily starting at 8 a.m. for the duration prescribed for each group.
Nine animals were used in three control groups, each consisting of three animals,
with a total of six eyes in each group. Group 1 – only saline eye drops were applied topi-
cally for 17 days (negative control). Group 2 – nimesulide (Alkan Pharmaceuticals, Ger-
many) 0.1% eye drops were instilled topically for seven days; nimesulide, was dissolved
in DMSO (Sigma, Germany). Methyl cellulose, in a concentration of 0.3%, was added to
prolong the contact with the eye. Group 3 – ketorolac tromethamin 0.5% eye drops, dis-
solved in 0.9% saline (Samulgin, Amoun Pharmaceuticals, Egypt) were applied topically
for seven days. Dry eye model was induced in three animal groups. In all three groups,
atropine sulphate 1% eye drops were instilled three times daily for 17 days. Group 4 –
animals received only atropine sulphate 1% eye drops. Group 5 – in addition to atropine
sulphate 1% eye drops, nimesulide 0.1% eye drops were applied topically three times
daily for seven days starting on day 10 (half an hour after each instillation of atropine
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sulphate). Group 6 – in addition to atropine sulphate 1% eye drops, ketorolac 0.5% eye
drops were applied topically three times daily for seven days starting on day 10 (half an
hour after each instillation of atropine sulphate).
Ophthalmological examination. – Rabbit eyes were examined daily with a naked eye
and by direct ophthalmoscope. All the animals were examined on days zero, 3, 7, 10, 14
and 17 of the experiment with the following tests.
Schirmer test. – Schirmer test-1 (without anaesthesia) was done to measure tear sec-
retion in response to both conjunctival stimulation and basal non-reflex secretion. It was
performed using Schirmer strips (SEPO, Egypt) which are made of filter paper of 0.5
mm width and 3.5 mm length. The strip was inserted over the inferior lid margin to-
wards the lateral canthus for five minutes. Eyes were left to blink normally. The wet area
was measured in millimeters (12).
Tear break-up time (TBUT). – Non invasive TBUT was measured with a hand held
tearscope-plus (2413-P-2003, Keeler, UK). The lids were blinked manually to distribute
the tear film, then the eye was held open and the time taken for distortion of the reflec-
ted image of the tearscope grid was recorded. In each measure, the test was performed
two times successively and the average was calculated (13).
Fluorescein corneal staining. – One drop of fluorescein sodium 1% eye drops (CID,
Egypt) was instilled in the conjunctival sac. Three minutes later, the eye was examined
using a direct ophthalmoscope with cobalt blue light. The numbers of stained corneal
quadrants (superior temporal, inferior temporal, superior nasal and inferior nasal) were
recorded. The score of this test was graded from 0 to 4 (0 = no staining) (14). The exami-
ner was blind-folded.
Histopathological examination. – Animals were killed at the end of the 17th day with
an overdose of intravenous pentobarbital sodium and their eyes were enucleated. Speci-
mens were taken from central corneas, temporal and nasal bulbar parts of conjunctiva.
Tissues were fixed in 10% formalin and processed to obtain paraffin blocks. Sections of
4-mm thickness were obtained and stained with haematoxylin and eosin stains. Sections
were examined by light microscopy to assess the histopathological changes of dryness
and inflammation.
Statistical analysis. – All results are expressed as mean ± SD. Comparison between
groups was performed using ANOVA followed by a post hoc test.
RESULTS AND DISCUSSION
Ophthalmological examination
All animals appeared normal on examination by naked eye and with a direct oph-
thalmoscope. However, it was noticed that nimesulide eye drops prepared in our labora-
tory were slightly irritant to rabbit eyes, causing transient moderate hyperemia. The rab-
bits were annoyed and some itching was observed for 5 minutes after eye drop
application, followed by spontaneous relief. Ketorolac did not show that effect.
Schirmer test values of control groups 2 and 3 were not significantly different from
those of group 1 (negative control) throughout the whole experiment. Table I shows the
165
A. H. M. El-Shazly et al.: Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits,
Acta Pharm. 58 (2008) 163–173.
Schirmer test values in the negative control group and in groups 4, 5 and 6 (dry eye mo-
del induction). There was a gradual and significant decrease in tear volume in the un-
treated dry eye model (group 4), reaching a mean of 4.17 ± 0.75 mm on the 17th day of
experiment as compared to the negative control group (18.83 ± 3.71) mm.
In groups 5 and 6 (dry eye model treated with nimesulide and ketorolac, respective-
ly), there was also a gradual decrease in tear volume until day 10 with values of 5.17 ±
1.17 mm and 6.0 ± 1.26 mm, respectively. After initial treatment, groups 5 and 6 showed
a significant improvement in Schirmer test values on day 17 (14.0 ± 4.2 and 18.0 ± 2.61
mm, respectively) compared to the untreated model of group 4 (4.17 ± 0.75 mm).
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Table I. Schirmer test valuesa
Day Group 1 Group 4 Group 5 Group 6






















































Data are expressed as mean ± SD, n = 6.
p1, p2, p3 compared to group 1, 4, 5, resp.
a Schirmer test value (mm) of negative control rabbits (group 1), rabbits with dry
eye model induced by atropine sulphate 1% eye drops three times daily for 17 days
(group 4) and rabbits with dry eye model treated 3 times daily for 7 days with eit-
her nimesulide 0.1% eye drops (group 5) or ketorolac 0.5% eye drops (group 6) star-
ting from day 10.
b Significant difference.
When the results of groups 5 and 6 were compared with those of group 1 (negative
control), there were significant differences in the Schirmer test measures on almost all
days of testing. Even after initial treatment, the tear volume measures improved but
they were still significantly lower than negative controls. The only exception is the result
of group 6 on day 17; ketorolac could improve the Schirmer test value not to be signifi-
cantly different from the negative control.
Comparing the results of groups 5 and 6 together, there was no significant differen-
ce between the two groups until day 10 (starting treatment). On days 14 and 17, ketoro-
lac improved the Schirmer test values more efficiently than nimesulide.
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Table II. Tear break-up time valuesa
Days Group 1 Group 4 Group 5 Group 6






















































Data are expressed as mean ± SD, n = 6.
p1, p2, p3, compared to group 1, 4, 5.
a Tear break-up time value (in seconds) of negative control rabbits (group 1), rabbits
with dry eye model induced by atropine sulphate 1% eye drops three times daily
for 17 days (group 4) and rabbits with dry eye model treated 3 times daily for 7
days with nimesulide 0.1% eye drops (group 5) or ketorolac 0.5% eye drops (group
6) starting from day 10.
b Significant difference.
All control groups showed no significant changes in TBUT throughont the experi-
ment. In the untreated dry eye model (group 4), TBUT values (in seconds) examined on
days 3, 7, 10, 14 and 17 were 12.3 ± 3.9, 7.5 ± 3.2, 4.0 ± 1.6, 2.5 ± 1.4 and 1.3 ± 1.2, respecti-
vely. Group 4 showed a significant decrease in TBUT compared to the negative control
of group 1, was 18.8 ± 5.2 on day 0 and 19.8 ± 3.9 on day 17 (Table II).
On treating the dry eye model with nimesulide (group 5) or ketorolac (group 6),
TBUT values improved significantly on day 14 (8.8 ± 2.7 and 8.8 ± 1.8, for groups 5 and
6, respectively). On day 17, they reached 13.5 ± 4.5 and 12.2 ± 3.8 for groups 5 and 6, res-
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Table III. Fluorescein corneal staining scoresa
Days Group 1 Group 4 Group 5 Group 6






















































Data are expressed as mean ± SD, n = 6.
p1, p2, p3, compared to group 1, 4, 5.
ª Fluorescein corneal staining scores (number of stained corneal quadrants)
of negative control rabbits (group 1), rabbits with dry eye model induced
by atropine sulphate 1% eye drops three times daily for 17 days (group 4)
and rabbits with dry eye model treated 3 times daily for 7 days with nime-
sulide 0.1% eye drops (group 5) or ketorolac 0.5% eye drops (group 6) star-
ting from day 10.
b Significant difference.
pectively. These values were still significantly lower than the negative controls. In addi-
tion, the effects of the two drugs were not significantly different (Table II).
The control groups (1, 2 and 3) showed almost complete absence of corneal fluores-
cein staining throughout the duration of the experiment. The untreated dry eye model
(group 4) showed a significant degree of corneal staining, with a mean of 3.8 ± 0.2 on
day 17, as compared to the negative control (group 1) that had a mean of 0.3 ± 0.5 (Table
III).
On days 10, 14 and 17, corneal staining values in group 5 were 2.5 ± 0.6, 1.3 ± 0.5
and 1.0 ± 0.6, respectively, and group 6 values were 1.5–0.6, 1.0–0.0 and 0.7–0.5, respecti-
vely. Group 5 and 6 values were significantly lower than the untreated model on days
10, 14 and 17, but they were still significantly higher than negative controls on the same
days. Only ketorolac could improve the fluorescein corneal staining to a level not to be
significantly different from negative controls on day 17 (Table III).
Comparing the effects of the two drugs together, there was no significant difference
in fluorescein corneal staining between the two except on day 10 (starting treatment) as
ketorolac produced a more significant effect than nimesulide (Table III).
Histopathological examinations
Histopathological examination of specimens taken from all control groups showed
normal appearance of the cornea and conjunctiva (Figs. 1a,b). The untreated dry eye mo-
del (group 4) revealed marked histopathological changes after 17 days of topical atropi-
ne administration. There are frequent areas of corneal epithelial abrasions and defects
with of signs of degeneration such as vacuolated basal epithelial cells leading to micro-
cystoid formation with alternate areas of epithelial cell loss and thinning (Figs. 2a,b). In
the same group, the conjunctival epithelium shows areas of squamous metaplasia, hy-
perplasia and keratinization. Inflammatory cells are infiltrating the subepithelium in the
form of lymphocytes, plasma cells and some eosinophils. Goblet cell hyperplasia is also
noticed with excessive retention of secretion (Fig. 2c).
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a) b)
Fig. 1. Light photomicrograph of corneal and conjunctival specimens from control animals showing:
a) normal corneal epithelium. Basal cells are columnar with two to three layers of overlying wing
cells and flat squamous cells at the apical surface; b) normal bulbar conjunctival epithelium. Epithe-
lial cells are cylindrical to cubical arranged in three to four layers with abundant goblet cells; hae-
matoxilin and eosin X200.
In animals of group 5 (receiving topical nimesulide as treatment for dry eye model),
histopathological examination of the cornea showed areas of proliferated epithelium
which filled the areas of previous focal defects with the appearance of clusters of clear
pinpoint microcysts, indicating healing of areas of previous corneal erosions (Fig. 3a).
The conjunctiva showed a reduction of epithelial hyperplasia, a decrease in inflamma-
tory cell reaction and retained secretions in goblet cells (Fig. 3b).
In animals treated with ketorolac (group 6), the specimens reveal signs of healing of
corneal erosions in the form of hyperplastic epithelium (Fig. 4a). The conjunctiva
showed reduced inflammatory reaction, epithelial hyperplasia and goblet cells hyper-
plasia, which was more marked in group 6 than in group 5 (Fig. 4b).
The results of the present study are in agreement with those of Sternlicht and Werb
(15), who stated that the increased matrix metalloproteinases in the tear fluid in KCS
cause lyses of corneal epithelium basement membrane and tight junction proteins. This
may lead to increased fluorescein permeability and staining, increased corneal desqua-
mation and punctuate epithelial erosions (15). Also, Dursun and coworkers (16) descri-
bed a mouse model of KCS with decreased tear volume, altered corneal epithelial barrier
function and hyperplasia of conjunctival epithelium. According to Libui et al. (4), dry
eye models induced inflammatory reactions that attract and retain inflammatory cells in
the conjunctiva (4).
In accord with our work are some reports investigating topical steroids (17),
NSAIDS (2, 17, 18) and cyclosporine A (19) for management of KCS. However, steroids
have multiple adverse effects including cataract and increased intraocular pressure (17).
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b)a)
c)Fig. 2. Light photomicrograph of corneal and
conjunctival specimens of untreated dry eye
model (group 4) showing: a) cornea with va-
cuolated basal epithelial cells and microcy-
stoid changes; b) corneal abrasion; c) conjunc-
tiva with subepithelial inflammatory infiltra-
tion, advanced intracellular edema with
decreased cytoplasmic density, goblet cell hy-
perplasia, excessive retention of secretion and
epithelial hyperplasia; haematoxilin and eo-
sin X400.
Moreover, ocular discomforts, including burning, stinging, conjunctival hyperemia and
systemic side effects, were reported in patients receiving topical cyclosporine A for 12
months (19). As regards the nonselective COX inhibitors, such as ketorolac, they can
gain access to the systemic circulation via nasolacrimal absorption (7), which may cause
bronchospasm in asthmatics and postoperative bleeding due to inhibition of platelet ag-
gregation (COX-1 dependent functions) (10).
In the present study, ketorolac produced more improvement compared to nimesuli-
de in the Schirmer test (18.0 ± 2.61 mm and 14.0 ± 4.2 mm, respectively) as well as fluo-
rescein corneal staining values (0.67–0.52 mm and 1.0–0.63 mm, respectively), approach-
ing the controls at the end of experiment (day 17). However, the results of nimesulide
were still significantly lower than the controls on day 17. Yet, the use of the selective
COX-2 inhibitor, nimesulide, is preferred to avoid the local and systemic side-effects en-
countered in prolonged and repeated treatments with the nonselective COX inhibitor,
ketorolac.
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b)a)
Fig. 3. Light photomicrograph of corneal and conjunctival specimens of dry eye model treated with
0.1% nimesulide eye drops (group 5) showing: a) cornea with areas of pinpoint microcytic clusters;
b) conjunctiva with marked reduction of epithelial hyperplasia, swollen goblet cells with retained
secretion and reduction of inflammatory cellular infiltration; haematoxilin and eosin X200.
b)a)
Fig. 4. Light photomicrograph of corneal and conjunctival specimens of dry eye model treated with
0.5% ketorolac eye drops (group 6) showing: a) cornea with areas of healed previous corneal erosions;
b) conjunctiva with decreased inflammatory cellular infiltration and reduction of goblet cell hyper-
plasia; haematoxilin and eosin X200.
CONCLUSIONS
Both nimesulide and ketorolac have beneficial effects in the management of atropi-
ne sulphate induced dry eye in albino rabbits. The transient ocular irritant effects produ-
ced by nimesulide eye drops, prepared in our laboratory, are better avoided and nonirri-
tant ocular preparations of nimesulide are suggested for further investigation. Further
studies are suggested to confirm the safety of nimesulide for prolonged therapy.
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S A @ E T A K
Usporedba dvaju inhibitora cikooksigenaze u eksperimentalnom
modelu suhog oka u albino kuni}a
AMANY HASSAN MOHAMED EL-SHAZLY, AMAL AHMAD EL-GOHARY,
LAILA HASSAN MOHAMED EL-SHAZLY i GHADA GHANEM EL-HOSSARY
Cilj istra`ivanja bila je usporedba topi~kog protuupalnog u~inka neselektivnog inhi-
bitora ciklooksigenaze (COX), ketorolaka i selektivnog COX-2 inhibitora, nimesulida na
animalnom modelu suhog oka u albino kuni}a. Na `ivotinjama je proveden Schirmerov
test, vrijeme prestanka suzenja oka (TBUT) i test bojenja ro`nice fluoresceinom. U ani-
malnom modelu suhog oka zna~ajno je smanjen volumen suza, TBUT, bojenje ro`nice i
histopatolo{ki simptomi suho}e i upale. Obradom suhog oka s kapima za o~i koje sa-
dr`e 0,1% nimesulida, odnosno 0,5% ketorolaka, pobolj{ane su vrijednosti u Schirmero-
vom testu, TBUT i bojanje ro`nice fluoresceinom, smanjena je upalna reakcija, a na oku
su se pokazali simptomi ozdravljenja i regeneracije. I nimesulid i ketorolak smanjuju su-
ho}u oka induciranu atropin sulfatom u albino kuni}a. Uporaba selektivnog COX-2 in-
hibitora, nimesulida, se preferira jer se izbjegavaju lokalne i sistemske nuspojave koje se
mogu pojaviti uz uporabu neselektivnog COX inhibitora, ketorolaka.
Klju~ne rije~i: model suhog oka, kuni}, atropin sulfat, Schirmerov test I, nimesulid, ketorolak
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